Literature DB >> 20213705

Bootstrap-based methods for estimating standard errors in Cox's regression analyses of clustered event times.

Yongling Xiao1, Michal Abrahamowicz.   

Abstract

We propose two bootstrap-based methods to correct the standard errors (SEs) from Cox's model for within-cluster correlation of right-censored event times. The cluster-bootstrap method resamples, with replacement, only the clusters, whereas the two-step bootstrap method resamples (i) the clusters, and (ii) individuals within each selected cluster, with replacement. In simulations, we evaluate both methods and compare them with the existing robust variance estimator and the shared gamma frailty model, which are available in statistical software packages. We simulate clustered event time data, with latent cluster-level random effects, which are ignored in the conventional Cox's model. For cluster-level covariates, both proposed bootstrap methods yield accurate SEs, and type I error rates, and acceptable coverage rates, regardless of the true random effects distribution, and avoid serious variance under-estimation by conventional Cox-based standard errors. However, the two-step bootstrap method over-estimates the variance for individual-level covariates. We also apply the proposed bootstrap methods to obtain confidence bands around flexible estimates of time-dependent effects in a real-life analysis of cluster event times.

Mesh:

Year:  2010        PMID: 20213705     DOI: 10.1002/sim.3807

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  8 in total

1.  Off-label indications for antidepressants in primary care: descriptive study of prescriptions from an indication based electronic prescribing system.

Authors:  Jenna Wong; Aude Motulsky; Michal Abrahamowicz; Tewodros Eguale; David L Buckeridge; Robyn Tamblyn
Journal:  BMJ       Date:  2017-02-21

2.  Derivation and validation of a multivariable model to predict when primary care physicians prescribe antidepressants for indications other than depression.

Authors:  Jenna Wong; Michal Abrahamowicz; David L Buckeridge; Robyn Tamblyn
Journal:  Clin Epidemiol       Date:  2018-04-18       Impact factor: 4.790

3.  Assessing the accuracy of using diagnostic codes from administrative data to infer antidepressant treatment indications: a validation study.

Authors:  Jenna Wong; Michal Abrahamowicz; David L Buckeridge; Robyn Tamblyn
Journal:  Pharmacoepidemiol Drug Saf       Date:  2018-04-23       Impact factor: 2.890

4.  Can Hyperparameter Tuning Improve the Performance of a Super Learner?: A Case Study.

Authors:  Jenna Wong; Travis Manderson; Michal Abrahamowicz; David L Buckeridge; Robyn Tamblyn
Journal:  Epidemiology       Date:  2019-07       Impact factor: 4.822

5.  Effect of an Electronic Medication Reconciliation Intervention on Adverse Drug Events: A Cluster Randomized Trial.

Authors:  Robyn Tamblyn; Michal Abrahamowicz; David L Buckeridge; Melissa Bustillo; Alan J Forster; Nadyne Girard; Bettina Habib; James Hanley; Allen Huang; Siyana Kurteva; Todd C Lee; Ari N Meguerditchian; Teresa Moraga; Aude Motulsky; Lina Petrella; Daniala L Weir; Nancy Winslade
Journal:  JAMA Netw Open       Date:  2019-09-04

6.  Nurse staffing practices and adverse events in acute care hospitals: The research protocol of a multisite patient-level longitudinal study.

Authors:  Christian M Rochefort; Michal Abrahamowicz; Alain Biron; Patricia Bourgault; Isabelle Gaboury; Jeannie Haggerty; Jane McCusker
Journal:  J Adv Nurs       Date:  2020-12-10       Impact factor: 3.187

7.  Association of Antidepressant Prescription Filling With Treatment Indication and Prior Prescription Filling Behaviors and Medication Experiences.

Authors:  Jenna Wong; Siyana Kurteva; Aude Motulsky; Robyn Tamblyn
Journal:  Med Care       Date:  2022-01-01       Impact factor: 2.983

8.  Validating surgical procedure codes for inflammatory bowel disease in the Swedish National Patient Register.

Authors:  Anders Forss; Pär Myrelid; Ola Olén; Åsa H Everhov; Caroline Nordenvall; Jonas Halfvarson; Jonas F Ludvigsson
Journal:  BMC Med Inform Decis Mak       Date:  2019-11-11       Impact factor: 2.796

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.